Patients with chronic heart failure (CHF) who have experienced a myocardial infarction (MI) will benefit from a -blocker

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1413, 2003-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patients with acute myocardial infarction (MI) benefit from early treatment with statins

By  

Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and β-Blockers: Subanalysis of the EPHESUS

By Zhang Zefeng   Mahoney Elizabeth M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 55-63

Adis International

Access to resources Recommend Favorite

Iron sucrose improves haematological and renal parameters in anaemic patients with chronic heart failure (CHF) and renal insufficiency

By  

Inpharma, Vol. 1, Iss. 1611, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Iron sucrose loading extends exercise capacity in patients with chronic heart failure (CHF) and iron deficiency

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Guidelines for effective secondary prevention for patients after myocardial infarction (MI) have been released by UK's NICE

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite